Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Vaxcyte, Inc. (PCVX) Institutional Ownership & Insider Trading

331 institutions reported holding Vaxcyte, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 53 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PCVXVaxcyte, Inc.Follow PCVX — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
9.0B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
9 Nov, in 16 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

331 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +2.3%.

Increased+123New+35Decreased-94Closed-44

Largest moves, shares (millions)

FMR+4.4MT. Rowe Price Associates+2.0MWellington Management Group+1.4MParadigm Biocapital Advisors-2.7MJennison Associates-1.2MWestfield Capital Management-1.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+12.0Sep 24+2.8Dec 24+5.2Mar 25+1.3Jun 25-4.3Sep 25+8.8Dec 25+7.6Mar 26+3.4Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26331167+2.3%123359444
Mar 26334163+5.4%124537620
Dec 25291154+6.2%88379437
Sep 25277143-2.9%94299735
Jun 25291147+0.9%123527166
Mar 25306145+3.8%116488861
Dec 24317141+2.1%134448055
Sep 24324135+10.7%123738117

Vaxcyte, Inc. — questions

Who owns Vaxcyte, Inc. stock?
331 institutions reported Vaxcyte, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (14.0%), Jupiter Topco LLC (12.1%), T. Rowe Price Investment Management, Inc. (8.2%).
Are Vaxcyte, Inc. insiders buying or selling?
53 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Vaxcyte, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.